How many drugs treat poor muscle coordination?

Drug Landscape tracks 1 marketed treatments for poor muscle coordination (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/poor-muscle-coordination.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

poor muscle coordination — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

poor muscle coordination (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

1 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating poor muscle coordination, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Addiclenz	ASPARTAME	Deseret Biologicals, Inc.	Standardized Chemical Allergen [EPC]

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Deseret Biologicals, Inc. · 1 drug in poor muscle coordination

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in poor muscle coordination:

Cite this brief

Drug Landscape (2026). poor muscle coordination — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/poor-muscle-coordination. Accessed 2026-06-10.

poor muscle coordination full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing